2024 - ELISA ORICCHIO

Elisa Oricchio is the Director of the Swiss Institute for Experimental Cancer Research (ISREC) and a professor at EPFL in Lausanne (Switzerland).
She received her Ph.D. in 2008 and did her post-doctoral training at Memorial Sloan Kettering Cancer Center, where she gained expertise in cancer genomics, genetic manipulation of transgenic animal models, and pre-clinical treatment studies.
Currently, research in her lab aims at systematically integrating genomic and functional analyses to identify oncogenic events in cancer and exploit this information for the design of novel therapies. 
Throughout her career, she has identified oncogenes or tumor suppressor genes as new therapeutic targets or as biomarkers to better classify cancer patients. She has integrated linear cancer genomic analyses with tridimensional analyses of the genome to better understand tumor development and evolution. 

Her work has been recognized with the Blavatnik Award for Young Scientist by the New York Academy of Science, the Lorini Award for Italian Scientist in Cancer Research, and in 2021 she received the Prix Leenaards for Translation Research.